Factsheet

Cell and Gene Therapy (CGT): Pre-launch checklist

Ten questions to ask yourself and your commercialization partner

As they embark on the commercialization path, it is essential for cell and gene therapy (CGT) developers, who invest their time, expertise, and financial resources to create groundbreaking therapies that profoundly impact patients' lives, to position themselves for optimal market access by engaging with the right stakeholders. Discover how selecting the right integrated commercialization solutions partner can help position your product for success.

The right partner will help streamline the intricate pre-launch process, assist you in tackling challenging decisions related to market access, distribution strategies, patient services, and more―ensuring all bases are covered.
checklist

Enter your information below to download the checklist and discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.

 

Pardot Form

Related resources

Article

From AI to regulatory layering and convergence: Key takeaways from RAPS Euro Convergence 2026

Article

How U.S. pricing reform is reshaping global market dynamics

Guide

Cell and gene therapy playbook for payer engagement: Translating payer expectations into actionable market access strategies

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract